Acorda Therapeutics Announces Acquisition of Two Neuropathic Pain Assets

by admin on July 9, 2013

Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. . Qutenza® is approved by the U.S.

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: